Latest Blog Posts Tagged "Alpha-Synuclein"
January 30, 2018
The Michael J. Fox Foundation, National Institutes of Health and five industry partners unite to find molecular difference in Parkinson's.
January 04, 2018
A recent study shows that the way people with Parkinson's process caffeine could help identify disease earlier.
November 17, 2017
Steve Hodges and the KiMe Fund focus on community involvement and funding researcher tools to ensure future generations don't have to live with Parkinson's.
October 17, 2017
Measuring a person's scent or eye movements could lead to earlier PD diagnosis.
October 13, 2017
Analysis from the MJFF-led PPMI points to potential use of these biomarkers for testing drug engagement but likely not for tracking short-term progression.
October 03, 2017
David Levine, MD, MPH, shares his experiences as a participant in the Levodopa Response Trial and thoughts on PD scientists using his data to advance research.
September 26, 2017
Read our biomarkers guide to learn more about how and why scientists are looking for objective medical tests for Parkinson's.
August 17, 2017
A new paper shows 67% of study participants who showed smell loss and dopamine loss in the brain developed PD over a four-year period. This strategy could help select people for research studies.
August 14, 2017
MJFF-funded consortium publishes on how best to test for the protein alpha-synuclein in blood and spinal fluid, which could lead to more accurate and replicable results.
August 02, 2017
Two studies using data from the MJFF-led Parkinson's Progression Markers Initiative point to brain imaging scans that could help advance drug trials.